Rare?diseases — including blood disorders like #MDS — impact millions of people worldwide. Whether it’s a friend, family member, or colleague, chances are you know someone affected by a?rare disease. ? Since 2008, #RareDiseaseDay?has played a critical part in building an international?rare disease?community that is united in purpose. #TeamGeron is proud to take part by raising awareness and working toward a brighter future for?patients living with a rare #BloodCancer.
Geron Corporation
生物技术研究
Foster City，California 15,582 位关注者
Changing lives by changing the course of blood cancer.
关于我们
Geron is a biopharmaceutical company that is charting a new course with the goal to deliver innovative treatment options for people living with blood cancer. Our tireless pursuit to improve outcomes for these patients resulted in the U.S. approval of the first ever telomerase inhibitor for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. As the sole company with an oligonucleotide telomerase inhibitor approved by the FDA, we feel a deep urgency to bring the potential power of telomerase inhibition to patients in need. We are conducting research in other blood cancers with high unmet need beyond LR-MDS, with ongoing clinical trials across other hematologic malignancies, including a pivotal Phase 3 clinical trial in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF). We are proud of the impact this Nobel-winning science is having in the fight against blood cancers. At Geron, we are united by a shared purpose: Every individual in every role can meaningfully contribute to our mission to change lives by changing the course of blood cancer. With a culture rooted in courage and determination, we will continue to innovate and pursue new possibilities for patients. To learn more, visit www.geron.com. Geron’s Community Guidelines: https://www.geron.com/CommunityGuidelines/
- 网站
-
https://www.geron.com
Geron Corporation的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Foster City，California
- 类型
- 上市公司
- 创立
- 1992
- 领域
- Oncology、Hematologic Malignancies和Telomerase Inhibition
地点
-
获取路线
919 E Hillsdale Blvd
US，California，Foster City，94404
Geron Corporation员工
动态
-
Meet Natasha M., Associate Director of Clinical Operations at Geron. ? Natasha?joined #TeamGeron with a deep commitment to pushing the boundaries of innovation in science, while contributing to the company’s mission to transform #CancerCare. In her role, she sees firsthand how diverse ideas and collaborative efforts shape innovation in the field of medicine. ? When she was new to the industry,?Natasha?often felt?pressured to?prove herself in spaces where few people looked like her. But a conversation with a senior Black colleague changed everything.?This colleague shared stories of resilience, teaching her that every step taken was not only for oneself but also for those who were previously denied opportunities and whose contributions were ignored due to discrimination and erasure.?For?Natasha, it was a powerful lesson in the importance of representation, diversity, and the strength that comes from different perspectives. ? February is #BlackHistoryMonth, and for?Natasha this has always been a time of reflection, honoring those who broke barriers and paved the way for people like her to be recognized for their work. "When we come together with the shared understanding of equality, purpose, and goal, we empower not only ourselves but the world," she says.
-
We have released Q4 and Full Year 2024 financial results and recent business highlights. We are proud of our 2024 accomplishments, including the U.S. commercial launch in June 2024 of our medicine for certain adults with lower-risk?#MDS with transfusion-dependent anemia, achieving 80% enrollment in our Phase 3 trial in relapsed/refractory myelofibrosis, and ending the year with a solid cash position. ? Learn more: https://lnkd.in/esgyg4KW
-
We plan to release our?Q4 and full-year 2024 financial results and business highlights on February 26 at 8 a.m. ET. Learn more:?https://lnkd.in/ej8ZPAsy
-
-
On the 10th?anniversary of the International Day of Women and Girls in Science, we celebrate the remarkable women of #TeamGeron whose leadership, resiliency and passion is not only helping to break down barriers in #BloodCancer, but inspiring the next generation to discover what’s possible when you work together towards a common goal. Thank you for the impact you continue to make at Geron and for your unwavering commitment to advancing science and to the patients who are counting on us every day!?#IDWGS
-
-
Every year on #WorldCancerDay, we are reminded of the strength and resilience of?cancer?patients, survivors, their caregivers, and the communities that support them.? ? This year's theme, #UnitedByUnique, underscores the fact that every person’s?cancer?journey is different. It’s a message that truly resonates with those of us that know and support people living with rare blood disorders like #MDS, where the bone marrow struggles to produce enough healthy blood cells.? ? Today?and every?day?at Geron, we honor their unique?stories, the challenges they face every?day?and our efforts to change lives by changing the course of blood?cancer. ?? Thank you to?the?Union for International Cancer Control (UICC) for their efforts?to support people living with?cancer?worldwide. Learn more here: https://lnkd.in/gAJXpEer
-
-
???#TeamGeron is back! The 2025 #MoveForMDS dates and locations have officially been announced.? ? ???Tampa, April 27? ???Chicago, May 18? ???New York City, October 5? ????Boston, October 19? ? In 2024, the MDS Foundation, Inc.?walks raised over $350,000 to support those impacted by #MDS and fund research, awareness, and patient care. We are proud to be a gold level sponsor and support their efforts for the fourth year in a row!?? ? Learn more about Move for MDS here:?https://moveformds.org/?
-
-
Meet?Marissa Cerniglia, Senior Manager, People Operations. Marissa?joined #TeamGeron with the goal of growing as an HR professional while also playing a role in the?company’s mission to transform?cancer?care. She’s particularly grateful for the opportunity to work alongside seasoned?colleagues, learning from their wealth of experience.?Contributing to an inclusive work environment where employees feel empowered is a big part of what drives her. As part of her role,?Marissa leads the onboarding efforts at Geron, ensuring that new employees have everything they need to succeed. “It’s rewarding to help others thrive in their roles and?contribute to the meaningful work we’re all here to do,” she says.?
-
If you've been watching Jeopardy!, you might’ve noticed a critical part of Geron’s science pop up in the “Spittin’ Science Facts” category!?????Think you know the answer? Give it a try below, and if you need a hint, we’ve got you covered:?https://lnkd.in/ecxHSVKg
-
-
Congratulations, Peggy Ann Torney! #TeamGeron is looking forward to working with you. Supporting the MDS Foundation, Inc.‘s efforts to drive awareness and accelerate research for #MDS is always such an honor.
The MDS Foundation is pleased to welcome, Peggy Ann Torney, as our Chief Executive Officer. ?? Throughout her career, Peggy Ann Torney has dedicated herself to serving those most in need. Her unwavering commitment to community engagement, health equity, and patient empowerment has been the cornerstone of her leadership and has helped organizations drive meaningful social change. Most recently, as Vice President of Communications at Murmuration, the nonprofit tech company founded by Emma Bloomberg, Peggy Ann leveraged data-driven strategies to amplify civic engagement and give voice to underserved communities – creating pathways to healthier, more equitable communities across the country. Prior to Murmuration, Peggy Ann spent nearly a decade at the Lymphoma Research Foundation (LRF). As Chief Strategy, Communications, and Engagement Officer, she championed patient education and advocacy while addressing critical healthcare disparities. Under her leadership, the Foundation significantly expanded its reach and impact through innovative awareness and education initiatives, including an award-winning mobile app that democratized access to critical disease information. By spearheading programs that broke down barriers to care and education, she ensured that even the most vulnerable members of the blood cancer community had the resources and support they needed to advocate for their care. Peggy Ann is committed to making knowledge accessible to all, and her multifaceted expertise also includes developing national science curricula at Macmillan/McGraw-Hill, telling compelling stories as a news producer at MSNBC, and raising the profile of nonprofit brands. Her genuine passion for connecting with diverse audiences has enabled her to transform complex ideas into clear, meaningful insights that empower people to have the information they need to make the best decisions for their futures. She holds a bachelor's degree from Fordham University and a master's degree from Columbia University School of Journalism. Peggy Ann brings not just a unique blend of scientific understanding, strategic communications, and patient advocacy, but a deeply held belief that every patient and loved one deserves access to the best possible care and support, which uniquely positions her to advance the MDS Foundation's mission of supporting patients, families, and healthcare professionals in the fight against myelodysplastic syndromes. Please join us in welcoming, Peggy Ann. #MDS #MDSF #MDSFoundation #HopeForMDS
-